Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Trading Statement

23 Oct 2020 07:00

RNS Number : 9651C
Ceiba Investments Limited
23 October 2020
Β 

23 October 2020

CEIBA INVESTMENTS LIMITED

(the "Company")

Β 

(TICKER CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

Β 

Β 

TRADING UPDATE

Β 

Β 

CEIBA Investments Limited ("CEIBA" or the "Company"), the largest listed foreign company solely dedicated to investing in Cuba, with interests in the commercial and tourism real estate sectors, is pleased to announce that on 20 October 2020 it executed a binding framework agreement with GBM Interinvest Technologies S.L. ("GBM IT") and GBM Interinvest Technologies Mariel S.L.("GBM IT Mariel") to further diversify its Cuban real estate portfolio by acquiring a 50% participation in GBM IT Mariel, which is spear-heading the development of a mixed use multi-phase industrial park (the "Project") to be located in the Special Development Zone of Mariel, Cuba ("ZED Mariel"). The initial investment of the Company in the Project will be limited to the amount of €1,500,000.

The Project

Β 

The Project of GBM IT Mariel is designed to develop and then operate a mixed use multi-phase industrial park to be constructed on an undeveloped tract of 11.3 hectares that will include industrial logistics, warehousing, production facilities, offices and other spaces located in the Special Development Zone of Mariel, Cuba. The first phase of the Project is due to start in 2021 and includes the construction of four warehouses with a total area of 11,000 square metres (118,400ft2). The Project is a 100% foreign investment, with no Cuban equity partner.

Β 

The participation of the Company in the Project demonstrates the strong leadership position of the Company in the Cuban real estate market. By entering into the strategic new market segment of industrial logistics, warehousing and production facilities and a new geographic location in the Special Development Zone of Mariel, the Company is diversifying its asset base and positioning itself to take early advantage of expected new areas of strong growth in the Cuban economy as the country focuses its efforts on local production of goods and the substitution of imports.

Β 

About GBM IT Mariel

GBM IT and GBM IT Mariel are Spanish limited liability companies. GBM IT Mariel was incorporated in 2019 for the purpose of developing the Project. It is the first international investor to have been authorized to construct, own and operate a large-scale industrial warehouse complex in Cuba without a Cuban equity partner. Its present shareholders have extensive experience in Cuba and were previously involved in the early development of the Company's largest asset, the Miramar Trade Centre.

Β 

About the Special Development Zone of Mariel

ZED Mariel was officially inaugurated in November 2013. So far, an infrastructure investment program in excess of US$1 billion has been carried out. As a Special Development Zone, ZED Mariel has a distinct legal regime and special rules governing corporate, banking, tax, employment and other matters, which are more favourable than those applicable elsewhere in the country.

Β 

ZED Mariel comprises a total area of 465 km2 and is located approximately 27 miles to the west of the city of Havana. It is connected by new road and railway links and its port is strategically positioned on the principal shipping route of the Gulf of Mexico, south of Florida and north of the Panama Canal.

Under the first phase of development, an area of approximately 45 km2 located on the western side of the Bay of Mariel is being developed as a regional and international shipping, trans-shipment, container, logistics and industrial production hub. The container terminal facility of ZED Mariel is managed by Singapore's PSA International. At present, there are 16 foreign capital companies and 5 joint venture companies operating in ZED Mariel, including companies owned by Unilever, NestlΓ©, British American Tobacco and Bouygues Construction. In addition, another 10 foreign capital companies and 7 joint venture companies have been authorized and are presently setting up operations.

Β 

Β 

Β 

For further information, please contact:

Β 

Aberdeen Standard Fund Managers Limited Tel: +44 (0)20 7463 6000

Sebastiaan Berger / Evan Bruce-GardyneΒ 

N+1 Singer Tel: +44 (0)20 7496 3000

James Maxwell / James Moat (Corporate Finance)

James Waterlow (Sales)

Β 

JTC Fund Solutions (Guernsey) Limited Tel: +44 (0)1481 702400

Β 

www.ceibainvestments.co.uk

Β 

END OF ANNOUNCEMENT

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTDZMZGKZFGGZM
12
Date   Source Headline
5th Jun 20268:33 amRNSTrading Update
27th May 20263:39 pmRNSHolding(s) in Company
22nd May 20262:30 pmRNSHolding(s) in Company
20th May 20263:37 pmRNSHolding(s) in Company
19th May 20261:07 pmRNSHolding(s) in Company
15th May 202612:40 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSIssue of Equity
30th Apr 20267:00 amRNSAnnual Financial Report
14th Apr 20264:46 pmRNSResult of EGM
1st Apr 202611:21 amRNSFurther re Second Amendment of Bond Instrument
27th Feb 20265:14 pmRNSFurther re Second Amendment of Bond Instrument
27th Feb 20262:26 pmRNSDirectorate change
13th Feb 20265:13 pmRNSStatement re Second Amendment of Bond Instrument
13th Feb 20263:20 pmRNSDirector Declaration
12th Feb 20265:32 pmRNSChange of Auditor
5th Feb 20267:00 amRNSTrading Update - Consultation with Bondholders
26th Jan 20263:36 pmRNSDirector/PDMR Shareholding
23rd Dec 20251:39 pmRNSNet Asset Value(s)
4th Dec 20253:25 pmRNSAppointment of Senior Independent Director
2nd Oct 20252:48 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSHalf-year Report
12th Sep 20253:16 pmRNSDirectorate Change
8th Jul 20257:00 amRNSTrading Update - Payment to Bondholders
4th Jul 202512:49 pmRNSDirectorate Change
3rd Jul 20253:14 pmRNSResult of AGM
1st Jul 20251:35 pmRNSNet Asset Value(s)
30th Apr 20257:00 amRNSAnnual Financial Report
28th Apr 202510:26 amRNSDirectorate Change
3rd Feb 20257:00 amRNSStatement re Amendment of Bond Instrument
13th Jan 20255:51 pmRNSStatement re Amendment of Bond Instrument
11th Dec 20241:31 pmRNSNet Asset Value(s)
7th Oct 202410:55 amRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSStatement re Update from the Chairman
27th Sep 20247:00 amRNSHalf-year Report to 30 June 2024
13th Aug 20248:36 amRNSDirectorate Change
20th Jun 20243:09 pmRNSDirector/PDMR Shareholding
20th Jun 20247:00 amRNSNet Asset Value(s)
18th Jun 20244:53 pmRNSResult of AGM
30th Apr 20247:00 amRNSAnnual Financial Report
25th Mar 202411:03 amRNSDirectorate Change
17th Jan 20247:00 amRNSInvestment Update
27th Dec 20239:17 amRNSNet Asset Value(s)
18th Dec 20238:54 amRNSDirector/PDMR Shareholding
3rd Nov 202310:36 amRNSHolding(s) in Company
1st Nov 20239:05 amRNSDirector/PDMR Shareholding
27th Oct 202311:11 amRNSDirector/PDMR Shareholding
16th Oct 20238:37 amRNSAppointment of Non-Executive Director
12th Oct 20234:26 pmRNSDirector/PDMR Shareholding
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.